Drug
TG 1801
TG 1801: highest development phase Phase 1, developed by TG Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- TG Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| TG-1801 NCT04806035 | Phase 1 | CLL |
| TG-1801 NCT03804996 | Phase 1 | B-Cell Lymphoma |
Latest
No recent events.
Follow TG 1801 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.